Reyedar develops eye-tracking technology for screening visual and neurodegenerative conditions.
Based in Groningen, Netherlands, Reyedar develops accessible screening tools for visual and neurodegenerative diseases. Its AI-powered infrared glasses measure eye movements, which algorithms analyse to provide clinical information and risk indicators. Founded in 2019 as a spin-off from the Ophthalmology Department of the University Medical Center, the company raised EUR 3 million in seed funding in July 2023, led by Cottonwood Technology Fund with participation from N.V. NOM, Pupil Labs, Uneti Ventures, and Blue Sparrows MedTech Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in